Analytical Data
-
基因名
FAXC
- Application
-
别名
Failed axon connections homolog
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q5TGI0
-
表达区间
1-409aa
-
氨基酸序列
MHWGVGFASSRPCVVDLSWNQSISFFGWWAGSEEPFSFYGDIIAFPLQDYGGIMAGLGSDPWWKKTLYLTGGALLAAAAYLLHELLVIRKQQEIDSKDAIILHQFARPNNGVPSLSPFCLKMETYLRMADLPYQNYFGGKLSAQGKMPWIEYNHEKVSGTEFIIDFLEEKLGVNLNKNLGPHERAISRAVTKMVEEHFYWTLAYCQWVDNLNETRKMLSLSGGGPFSNLLRWVVCHITKGIVKREMHGHGIGRFSEEEIYMLMEKDMRSLAGLLGDKKYIMGPKLSTLDATVFGHLAQAMWTLPGTRPERLIKGELINLAMYCERIRRKFWPEWHHDDDNTIYESEESSEGSKTHTPLLDFSFYSRTETFEDEGAENSFSRTPDTDFTGHSLFDSDVDMDDYTDHEQCK
-
分子量
73.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on FAXC recombinant proteins is rooted in the growing need to understand complex biological processes and their implications in various physiological and pathological conditions. FAXC, a member of the FAX family of proteins, plays a critical role in cellular signaling, immune responses, and development. The dysfunctional expression or mutations in FAXC have been implicated in several diseases, including cancers and autoimmune disorders. As such, scientists have turned to recombinant protein technology to produce FAXC in a controlled laboratory environment, allowing for detailed studies on its structure, function, and interactions with other biomolecules. By characterizing recombinant FAXC proteins, researchers aim to elucidate their role in disease mechanisms, identify potential therapeutic targets, and develop diagnostic tools. The advances in molecular cloning, expression systems, and purification techniques have facilitated significant progress in this field, paving the way for innovative approaches in drug discovery and biotechnology applications. Understanding FAXC at the molecular level holds promise not only for fundamental biology but also for the development of novel therapeutic strategies.
